CREON 1224 (Creon 120,000 units amylase / 24,000 units lipase / 76,000 units protease)

Generic Name: pancrelipase

Pill imprint CREON 1224 has been identified as Creon 120,000 units amylase / 24,000 units lipase / 76,000 units protease.

Creon is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Creon 120,000 units amylase / 24,000 units lipase / 76,000 units protease is not subject to the Controlled Substances Act.

See also related documents.

Images for CREON 1224 (Creon 120,000 units amylase / 24,000 units lipase / 76,000 units protease)

Creon 120,000 units amylase / 24,000 units lipase /  76,000 units protease CREON 1224
Creon
Generic Name:
pancrelipase
Imprint:
CREON 1224
Strength:
120,000 units amylase / 24,000 units lipase / 76,000 units protease
Color:
Orange / Clear
Size:
11.00 mm
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Digestive enzymes
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Solvay Pharmaceuticals Inc.
National Drug Code (NDC):
00032-1224
Inactive Ingredients:
cetyl alcohol
dimethicone
triethyl citrate
hypromelloses
polyethylene glycol

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web2)